These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36529933)

  • 1. Operational tolerance after intestine re-transplantation in childhood and immunological correlates. Case report and review.
    Remaley L; Ashokkumar C; Soltys KA; Mazariegos GV; Bond GJ; Khanna A; Ganoza A; Reyes-Mugica M; Zeevi A; Sindhi R
    Pediatr Transplant; 2023 May; 27(3):e14455. PubMed ID: 36529933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Operational tolerance in intestinal transplantation.
    Kroemer A; Khan K; Kaufman SS; Kang J; Weiner J; Duttargi A; Belyayev L; Ashokkumar C; Sindhi R; Timofeeva OA; Zasloff M; Matsumoto CS; Fishbein TM
    Am J Transplant; 2021 Feb; 21(2):876-882. PubMed ID: 32721092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans.
    Hornick PI; Mason PD; Yacoub MH; Rose ML; Batchelor R; Lechler RI
    Circulation; 1998 Apr; 97(13):1257-63. PubMed ID: 9570195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.
    Hu H; Zhu X; Joshi S; Lu L; Xia CQ; Patel JM
    PLoS One; 2015; 10(5):e0124705. PubMed ID: 25933390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Leuven Immunomodulatory Protocol Promotes T-Regulatory Cells and Substantially Prolongs Survival After First Intestinal Transplantation.
    Ceulemans LJ; Braza F; Monbaliu D; Jochmans I; De Hertogh G; Du Plessis J; Emonds MP; Kitade H; Kawai M; Li Y; Zhao X; Koshiba T; Sprangers B; Brouard S; Waer M; Pirenne J
    Am J Transplant; 2016 Oct; 16(10):2973-2985. PubMed ID: 27037650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic establishment and maintenance of the human intestinal B cell population and repertoire following transplantation in a pediatric-dominated cohort.
    Fu J; Hsiao T; Waffarn E; Meng W; Long KD; Frangaj K; Jones R; Gorur A; Shtewe A; Li M; Muntnich CB; Rogers K; Jiao W; Velasco M; Matsumoto R; Kubota M; Wells S; Danzl N; Ravella S; Iuga A; Vasilescu ER; Griesemer A; Weiner J; Farber DL; Luning Prak ET; Martinez M; Kato T; Hershberg U; Sykes M
    Front Immunol; 2024; 15():1375486. PubMed ID: 39007142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.
    Trivedi HL; Vanikar AV; Modi PR; Shah VR; Vakil JM; Trivedi VB; Khemchandani SI
    Transplant Proc; 2005 Mar; 37(2):737-42. PubMed ID: 15848518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CMV Primary Infection Is Associated With Donor-Specific T Cell Hyporesponsiveness and Fewer Late Acute Rejections After Liver Transplantation.
    Shi XL; de Mare-Bredemeijer EL; Tapirdamaz Ö; Hansen BE; van Gent R; van Campenhout MJ; Mancham S; Litjens NH; Betjes MG; van der Eijk AA; Xia Q; van der Laan LJ; de Jonge J; Metselaar HJ; Kwekkeboom J
    Am J Transplant; 2015 Sep; 15(9):2431-42. PubMed ID: 25943855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of CD127 combined with FOXP3 for identification of operational tolerance after liver transplantation.
    Nafady-Hego H; Li Y; Ohe H; Elgendy H; Zhao X; Sakaguchi S; Bishop GA; Koshiba T
    Transpl Immunol; 2016 May; 36():1-8. PubMed ID: 27105585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fingerprints of transplant tolerance suggest opportunities for immunosuppression minimization.
    Sarwal MM
    Clin Biochem; 2016 Mar; 49(4-5):404-10. PubMed ID: 26794635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infusion of Lin- bone marrow cells results in multilineage macrochimerism and skin allograft tolerance in minimally conditioned recipient mice.
    Anam K; Amare MF; Zins SR; Davis TA
    Transpl Immunol; 2010 Oct; 24(1):69-75. PubMed ID: 20950686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operational tolerance after pediatric composite liver-pancreas-intestine transplantation following severe graft-versus-host disease.
    Osborn J; Nathan JD; Tiao G; Alonso M; Kocoshis S
    Pediatr Transplant; 2021 Sep; 25(6):e14069. PubMed ID: 34125501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges with Intestine and Multivisceral Re-Transplantation: Importance of Timing of Re-Transplantation and Optimal Immunosuppression.
    Kubal CA; Pennington C; Fridell J; Ekser B; Muhaylov P; Mangus R
    Ann Transplant; 2018 Feb; 23():98-104. PubMed ID: 29402878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaching the promise of operational tolerance in clinical transplantation.
    Bishop GA; Ierino FL; Sharland AF; Hall BM; Alexander SI; Sandrin MS; Coates PT; McCaughan GW
    Transplantation; 2011 May; 91(10):1065-74. PubMed ID: 21544029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
    Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates.
    Bestard O; Cruzado JM; Mestre M; Caldés A; Bas J; Carrera M; Torras J; Rama I; Moreso F; Serón D; Grinyó JM
    J Immunol; 2007 Oct; 179(7):4901-9. PubMed ID: 17878390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.